Liver Cirrhosis Study (Hepatic Encephalopathy)

Now Enrolling in Salt Lake City

● Now Enrolling

About this research study

Liver cirrhosis is a late stage of liver disease in which liver tissue is permanently damaged and scarred. Scarred tissue prevents the liver from working normally which can lead to liver failure. Hepatic encephalopathy (HE) is a reversible neurological disorder that occurs in 30-45% of patients diagnosed with liver cirrhosis.

Velocity is conducting a Phase 3 clinical trial for an investigational medication intended to delay encephalopathy decompensation in patients with liver cirrhosis.

Eligible participants...

Must be age 18 to 85
Must have a diagnosis of liver cirrhosis with medically controlled ascites for more than 30 days
Must NOT have an active COVID-19 infection
Must NOT have had Epstein Barr Virus (EBV) or acute kidney injury from Hepatorenal syndrome (HRS) within the past 6 months
Must NOT have Wernicke’s or Wernicke-Korsakoff encephalopathy
Will receive compensation for study-related time
Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.

More information about participating in a clinical trial...

After you submit your information, a Velocity enrollment specialist will contact you.

Participating in a study is an important decision — we’re here to help you before, during, and after studies.

Please note: Health insurance is NOT required to join.

Is participation voluntary after I submit my information?

Yes. Participation in a study is entirely voluntary. In the informed consent process, you’ll learn about the product being studied, the participant’s role in the study, potential side effects, the number of visits that may be required, and more. Participants must sign an informed consent form to join the study.

Will I receive compensation?

While participation in a clinical study is voluntary, you may be paid for study-related time. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. Staff at the research clinic will discuss possible payment with you.

Enter your info

URL

This field is for validation purposes and should be left unchanged.

Name(Required)

Phone(Required)

Date of birth(Required)

Age can help us determine study eligibility (you must be age 18 or older to submit this form).

Month

Day

Year

Location and study of interest(Required)

Gender

Preferred language

Are you Hispanic or Latino?(Required)

Race(Required)

Select one or more designations that best describe you. This information can help Velocity better ensure all populations are represented in research.

American Indian or Alaskan Native

Asian

Black or African American

Native Hawaiian or Other Pacific Islander

White or Caucasian

This field is hidden when viewing the form

MobileOptIn

By entering your email address and/or phone number on this form, you represent that you are at least 18 years of age and you consent to receiving telephone calls and/or emails from Velocity Clinical Research or a third party on behalf of Velocity Clinical Research. For any help regarding messaging, please email us at [email protected]. For full details, refer to Velocity's privacy policy and website terms of use. Submissions on this website are not monitored 24/7. Do NOT submit personal health or medical information on this form. If you are enrolled in a trial and have questions, please call your research site.

Study Locations

Salt Lake City (West Jordan), Utah • Velocity Clinical Research

3590 West 9000 South, Suite 300, West Jordan, UT 84088
Phone: (801) 542-8190